IP Library › Granted Patent US 12,551,259
Granted Patent B2
US 12,551,259 · App. 17/793,154 · Granted Feb 17, 2026

Systems and methods for treatment of obstructive sleep apnea

Inventors: Orhan Soykan (Lino Lakes, MN); Mark Christopherson (Shoreview, MN); Donald A. Gonzales (Folsom, LA); Stefan Skorich (St. Louis Park, MN); Guy Vanney (Blaine, MN); Douglas Krone (Shoreview, MN)
Assignee: CRYOSA, INC.
A61B18/0206A61B17/24A61F7/12A61B2017/00106A61B2018/00577A61B2018/00714A61B2018/00875A61B2018/0212A61B2018/0262
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,551,259
App. No.
17/793,154
Granted
Feb 17, 2026
Kind
B2
Abstract

Methods, devices, and systems employ cryolysis of oropharyngeal adipose tissues to selectively remove fat cells from the tissues causing obstructive sleep apnea. In various embodiments, a chilled liquid—e.g., a liquid or air—is applied to the target tissue at a temperature and for a duration sufficient to cause cryolysis.

Claims (33)

1 . A device configured for treatment of obstructive sleep apnea, comprising:

an applicator configured to receive a circulating fluid from a temperature determinant, the applicator being sized and configured to contact an oropharyngeal tissue and including—

a bottom half having a tissue contacting surface and a temperature sensor positioned at the tissue contacting surface, and

a top half coupled to the bottom half and having one or more leads coupled to the temperature sensor, wherein the one or more leads extend from the bottom half of the applicator to the temperature sensor;

a fixture arm configured to be coupled to the applicator and adjust the applicator with respect to a positioning of the tissue contacting surface, the fixture arm including an electrical circuit electrically coupled to the temperature sensor; and

a controller configured to facilitate heat transfer between the applicator and the circulating fluid.

2 . The device of claim 1 , further comprising open foam insulation disposed on all surfaces of the applicator that are not intended to come in contact with tissue.

3 . The device of claim 1 , further comprising closed foam insulation disposed on all surfaces of the applicator that are not intended to come in contact with tissue.

4 . The device of claim 1 , further comprising a cryoprotectant sheet disposed on the tissue contacting surface of the applicator.

5 . The device of claim 1 , wherein the applicator comprises an insulator disposed on all surfaces of the applicator that are not intended to come into contact with tissue, the applicator further comprising a cryoprotectant sheet that covers the applicator including the insulator.

6 . The device of claim 1 , further comprising a first temperature sensor disposed on a fluid inlet of the applicator, a second temperature sensor disposed on a fluid outlet of the applicator, a third temperature sensor disposed on the tissue contacting surface of the applicator, and a fourth temperature sensor disposed on or in a cryoprotectant sheet of the applicator.

7 . The device of claim 1 , further comprising one or more passages disposed within or on the applicator for the one or more leads.

8 . The device of claim 1 , wherein the fixture arm is configured to apply a predetermined force from the tissue contacting surface of the applicator to the oropharyngeal tissue.

9 . The device of claim 1 , wherein the applicator includes (i) one or more fluid channels for the circulating fluid to flow through the applicator and (ii) one or more passages for the one or more leads to extend from the bottom half of the applicator to the temperature sensor.

10 . The device of claim 1 , wherein the applicator includes (i) one or more fluid channels for the circulating fluid to flow through the applicator, and (ii) one or more passages for the one or more leads to extend from the bottom half of the applicator to the temperature sensor, wherein the one or more passages are distinct from the one or more fluid channels.

11 . The device of claim 1 , wherein the fixture arm includes a flex circuit electrically coupled to the temperature sensor and incorporated into the fixture arm.

12 . A device for treatment of obstructive sleep apnea, the device comprising:

an applicator configured to receive a circulating fluid from a temperature determinant, the applicator being sized and configured to contact an oropharyngeal tissue and including—

a bottom half having a tissue contacting surface and a temperature sensor positioned at the tissue contacting surface, and

a top half coupled to the bottom half and having one or more leads coupled to the temperature sensor, wherein the one or more leads extend from the bottom half of the applicator to the temperature sensor;

a fixture arm configured to be coupled to the applicator and adjust the applicator with respect to a positioning of the tissue contacting surface;

a feedback system operably coupled to the temperature sensor and configured to monitor one or more temperature measurements at the tissue contacting surface; and

a controller configured to facilitate heat transfer between the applicator and the circulating fluid based on the feedback system.

13 . The device of claim 12 , wherein the controller is configured to adjust a temperature of the circulating fluid and a treatment duration based on the one or more temperature measurements from the set of temperature sensors.

14 . The device of claim 12 , wherein the one or more temperature measurements comprise a morphology that includes time constants, discontinuities, rate of change, area under a curve, or oscillations.

15 . The device of claim 12 , wherein the bottom half of the applicator has a at least one pressure sensor positioned at the tissue contacting surface, and the one or more leads are coupled to the at least one pressure sensor, and wherein the feedback system is operably coupled to the at least one pressure sensor and configured to monitor one or more pressure measurements at the tissue contacting surface.

16 . The device of claim 12 , wherein the fixture arm is coupled to the applicator at an attachment point and wherein the attachment point is positioned on the top half of the applicator such that a force applied to the fixture arm is distributed uniformly by the tissue contacting surface over the oropharyngeal tissue.

17 . The device of claim 12 , wherein the fixture arm is coupled to the applicator at an attachment point, and wherein the attachment point is a gimbal-type attachment.

18 . A device configured for treatment of obstructive sleep apnea, comprising:

an applicator configured to receive a circulating fluid from a temperature determinant, the applicator being sized and configured to contact an oropharyngeal tissue and including—

a bottom portion having a tissue contacting surface and a temperature sensor positioned at the tissue contacting surface, and

a top portion coupled to the bottom portion and having one or more leads coupled to the temperature sensor, wherein the one or more leads extend from the bottom portion of the applicator toward the temperature sensor; and

a fixture arm configured to be coupled to the applicator and adjust the applicator with respect to a positioning of the tissue contacting surface.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2023
From: SOYKAN, ORHAN; CHRISTOPHERSON, MARK; GONZALES, DONALD A.; SKORICH, STEFAN; VANNEY, GUY; KRONE, DOUGLAS
To: CRYOSA, INC.
Reel/Frame 063359/0488 →
Continuity (3)
Provisional Application 63132869 · Dec 31, 2020
Provisional Application 62978653 · Feb 19, 2020
Related Publication 20230069123A1 · Mar 2, 2023
References Cited (388)
US 3712306A · Bryne · 1973 [cited by applicant]
US 5245023A · Peoples et al. · 1993 [cited by applicant]
US 5250430A · Peoples et al. · 1993 [cited by applicant]
US 5534432A · Peoples et al. · 1996 [cited by applicant]
US 5663063A · Peoples et al. · 1997 [cited by applicant]
US 5743904A · Edwards · 1998 [cited by applicant]
US 5800379A · Edwards · 1998 [cited by applicant]
US 6017337A · Pira · 2000 [cited by applicant]
US 6032675A · Rubinsky · 2000 [cited by applicant]
US 6041787A · Rubinsky · 2000 [cited by applicant]
US 6045549A · Smethers et al. · 2000 [cited by applicant]
US 6126657A · Edwards et al. · 2000 [cited by applicant]
US 6245537B1 · Williams et al. · 2001 [cited by applicant]
US 6316262B1 · Huisman et al. · 2001 [cited by applicant]
US 6378525B1 · Beyar et al. · 2002 [cited by applicant]
US 6408851B1 · Karell · 2002 [cited by applicant]
US 6514515B1 · Williams · 2003 [cited by applicant]
US 6548569B1 · Williams et al. · 2003 [cited by applicant]
US 6555123B2 · Williams et al. · 2003 [cited by applicant]
US 6585994B2 · Williams et al. · 2003 [cited by applicant]
US 6592892B1 · Williams · 2003 [cited by applicant]
US 6593116B1 · Huisman et al. · 2003 [cited by applicant]
US 6607517B1 · Dae et al. · 2003 [cited by applicant]
US 6610764B1 · Martin et al. · 2003 [cited by applicant]
US 6623749B2 · Williams et al. · 2003 [cited by applicant]
US 6689589B2 · Huisman et al. · 2004 [cited by applicant]
US 6746447B2 · Davison et al. · 2004 [cited by applicant]
US 6746685B2 · Williams et al. · 2004 [cited by applicant]
US 6770071B2 · Woloszko et al. · 2004 [cited by applicant]
US 6828357B1 · Martin et al. · 2004 [cited by applicant]
US 6838493B2 · Williams et al. · 2005 [cited by applicant]
US 6867247B2 · Williams et al. · 2005 [cited by applicant]
US 6867248B1 · Martin et al. · 2005 [cited by applicant]
US 6878758B2 · Martin et al. · 2005 [cited by applicant]
US D568258S · Adam · 2008 [cited by applicant]
US 7367341B2 · Anderson et al. · 2008 [cited by applicant]
US 7458932B2 · Sun · 2008 [cited by applicant]
US 7507235B2 · Keogh et al. · 2009 [cited by applicant]
US 7575870B1 · Lalvani et al. · 2009 [cited by applicant]
US 7713266B2 · Elkins et al. · 2010 [cited by applicant]
US 7842029B2 · Anderson et al. · 2010 [cited by applicant]
US 7850683B2 · Elkins et al. · 2010 [cited by applicant]
US 7854754B2 · Ting et al. · 2010 [cited by applicant]
US 7862558B2 · Elkins et al. · 2011 [cited by applicant]
US 7998137B2 · Elkins et al. · 2011 [cited by applicant]
US 8192474B2 · Levinson · 2012 [cited by applicant]
US 8275442B2 · Allison · 2012 [cited by applicant]
US 8285390B2 · Levinson et al. · 2012 [cited by applicant]
US 8287579B2 · Nimitz · 2012 [cited by applicant]
US 8298216B2 · Burger et al. · 2012 [cited by applicant]
US 8337539B2 · Ting et al. · 2012 [cited by applicant]
US 8409185B2 · Burger et al. · 2013 [cited by applicant]
US 8523927B2 · Levinson et al. · 2013 [cited by applicant]
US 8603073B2 · Allison · 2013 [cited by applicant]
US 8676338B2 · Levinson · 2014 [cited by applicant]
US 8702774B2 · Baker et al. · 2014 [cited by applicant]
US 8715275B2 · Burger et al. · 2014 [cited by applicant]
US 8768468B2 · Garcia et al. · 2014 [cited by applicant]
US 8834547B2 · Anderson et al. · 2014 [cited by applicant]
US 8840608B2 · Anderson et al. · 2014 [cited by applicant]
US 9033966B2 · McKay · 2015 [cited by applicant]
US 9039688B2 · Palmer et al. · 2015 [cited by applicant]
US 9072498B2 · Elkins et al. · 2015 [cited by applicant]
US 9078634B2 · Gonzales et al. · 2015 [cited by applicant]
US 9101346B2 · Burger et al. · 2015 [cited by applicant]
US 9113855B2 · Burger et al. · 2015 [cited by applicant]
US 9254162B2 · Burger et al. · 2016 [cited by applicant]
US 9295512B2 · Allison et al. · 2016 [cited by applicant]
US 9308120B2 · Anderson et al. · 2016 [cited by applicant]
US 9314290B2 · Fourkas et al. · 2016 [cited by applicant]
US 9345526B2 · Elkins et al. · 2016 [cited by applicant]
US 9402676B2 · Babkin et al. · 2016 [cited by applicant]
US 9408745B2 · Levinson et al. · 2016 [cited by applicant]
US 9439805B2 · Gonzales et al. · 2016 [cited by applicant]
US 9545523B2 · Nanda · 2017 [cited by applicant]
US 9610112B2 · Karnik et al. · 2017 [cited by applicant]
US 9844461B2 · Levinson et al. · 2017 [cited by applicant]
US 9861421B2 · O'Neil et al. · 2018 [cited by applicant]
US 9907693B2 · Burger et al. · 2018 [cited by applicant]
US 9980765B2 · Avram et al. · 2018 [cited by applicant]
US 10085881B2 · Karnik et al. · 2018 [cited by applicant]
US 10092346B2 · Levinson et al. · 2018 [cited by applicant]
US 10111774B2 · Gonzales et al. · 2018 [cited by applicant]
US 10201380B2 · DeBenedictis et al. · 2019 [cited by applicant]
US 10213244B2 · Fourkas et al. · 2019 [cited by applicant]
US 10363080B2 · Elkins et al. · 2019 [cited by applicant]
US 10441459B2 · Aronhalt et al. · 2019 [cited by applicant]
US 10470813B2 · Allison et al. · 2019 [cited by applicant]
US 10568759B2 · Yee et al. · 2020 [cited by applicant]
US 10575890B2 · DeBenedictis et al. · 2020 [cited by applicant]
US 10582960B2 · Avram et al. · 2020 [cited by applicant]
US 10596030B2 · Karnik et al. · 2020 [cited by applicant]
US 10646666B2 · Cohn et al. · 2020 [cited by applicant]
US 10675178B2 · Levinson et al. · 2020 [cited by applicant]
US 10806500B2 · DeBenedictis et al. · 2020 [cited by applicant]
US 10864112B2 · Burger et al. · 2020 [cited by applicant]
US 10869779B2 · Burger et al. · 2020 [cited by applicant]
US 10888366B2 · Allison et al. · 2021 [cited by applicant]
US 10912599B2 · O'Neil et al. · 2021 [cited by applicant]
US 10939947B2 · Burger et al. · 2021 [cited by applicant]
US 11076879B2 · Yee et al. · 2021 [cited by applicant]
US 11116566B2 · Dinger et al. · 2021 [cited by applicant]
US 11154418B2 · Frangineas · 2021 [cited by applicant]
US 11253393B2 · Karnik et al. · 2022 [cited by applicant]
US 11272972B2 · Allison et al. · 2022 [cited by applicant]
US 11284934B2 · Lazarus et al. · 2022 [cited by applicant]
US 11324673B2 · Velis et al. · 2022 [cited by applicant]
US 11419757B2 · Gonzales et al. · 2022 [cited by applicant]
US 11437150B2 · Rondoni et al. · 2022 [cited by applicant]
US 11439532B2 · Velis · 2022 [cited by applicant]
US 11446175B2 · Jimenez Lozano et al. · 2022 [cited by applicant]
US 11446178B2 · Velis · 2022 [cited by applicant]
US D967164S · Mairs et al. · 2022 [cited by applicant]
US 11457971B2 · Wolf et al. · 2022 [cited by applicant]
US 11478643B2 · Verzal et al. · 2022 [cited by applicant]
US 11504322B2 · Garibyan et al. · 2022 [cited by applicant]
US 11510722B2 · Wolf et al. · 2022 [cited by applicant]
US 11511117B2 · Ni et al. · 2022 [cited by applicant]
US D971935S · Mairs et al. · 2022 [cited by applicant]
US D971936S · Mairs et al. · 2022 [cited by applicant]
US D971937S · Mairs et al. · 2022 [cited by applicant]
US D971950S · Mairs et al. · 2022 [cited by applicant]
US 11517365B1 · Mazor et al. · 2022 [cited by applicant]
US 11583438B1 · Levinson et al. · 2023 [cited by applicant]
US 20020026226A1 · Ein · 2002 [cited by applicant]
US 20020062831A1 · Beyar et al. · 2002 [cited by applicant]
US 20020164729A1 · Skral et al. · 2002 [cited by applicant]
US 20030060685A1 · Houser · 2003 [cited by applicant]
US 20030069572A1 · Wellman · 2003 [cited by applicant]
US 20030220374A1 · Needleman · 2003 [cited by applicant]
US 20030220674A1 · Anderson et al. · 2003 [cited by applicant]
US 20040234576A1 · Martin et al. · 2004 [cited by applicant]
US 20040249416A1 · Yun et al. · 2004 [cited by applicant]
US 20050043682A1 · Kucklick · 2005 [cited by applicant]
US 20050133026A1 · Seleznev et al. · 2005 [cited by applicant]
US 20060235264A1 · Vassallo · 2006 [cited by applicant]
US 20070010861A1 · Anderson et al. · 2007 [cited by applicant]
US 20070129714A1 · Elkins et al. · 2007 [cited by applicant]
US 20070144539A1 · van der Burg et al. · 2007 [cited by applicant]
US 20070154538A1 · Neuberger et al. · 2007 [cited by applicant]
US 20070163603A1 · Sikora · 2007 [cited by applicant]
US 20070198071A1 · Ting et al. · 2007 [cited by applicant]
US 20070255362A1 · Levinson et al. · 2007 [cited by applicant]
US 20070270925A1 · Levinson · 2007 [cited by applicant]
US 20080023012A1 · Dineen et al. · 2008 [cited by applicant]
US 20080058584A1 · Hirotsuka et al. · 2008 [cited by applicant]
US 20080066769A1 · Dineen et al. · 2008 [cited by applicant]
US 20080066864A1 · Ballantine et al. · 2008 [cited by applicant]
US 20080077201A1 · Levinson et al. · 2008 [cited by applicant]
US 20080077202A1 · Levinson et al. · 2008 [cited by applicant]
US 20080077211A1 · Levinson et al. · 2008 [cited by applicant]
US 20080083461A1 · Viken · 2008 [cited by applicant]
US 20080132891A1 · Nobis · 2008 [cited by applicant]
US 20080183164A1 · Elkins et al. · 2008 [cited by applicant]
US 20080188947A1 · Sanders · 2008 [cited by applicant]
US 20080200910A1 · Bur er et al. · 2008 [cited by applicant]
US 20080287839A1 · Rosen et al. · 2008 [cited by applicant]
US 20090014012A1 · Sanders · 2009 [cited by applicant]
US 20090018623A1 · Levinson et al. · 2009 [cited by applicant]
US 20090018624A1 · Levinson et al. · 2009 [cited by applicant]
US 20090018625A1 · Levinson et al. · 2009 [cited by applicant]
US 20090018626A1 · Levinson et al. · 2009 [cited by applicant]
US 20090018627A1 · Levinson et al. · 2009 [cited by applicant]
US 20090107001A1 · McCarthy · 2009 [cited by applicant]
US 20090118722A1 · Ebbers et al. · 2009 [cited by applicant]
US 20090120446A1 · Vaska et al. · 2009 [cited by applicant]
US 20090123886A1 · Vaska et al. · 2009 [cited by applicant]
US 20090149929A1 · Levinson et al. · 2009 [cited by applicant]
US 20090192504A1 · Askew · 2009 [cited by applicant]
US 20090287060A1 · Pell et al. · 2009 [cited by applicant]
US 20090287210A1 · Kauphusman · 2009 [cited by applicant]
US 20100057065A1 · Krimsky · 2010 [cited by examiner]
US 20100081971A1 · Allison · 2010 [cited by applicant]
US 20100100089A1 · Niethammer · 2010 [cited by applicant]
US 20100152824A1 · Allison · 2010 [cited by applicant]
US 20100280582A1 · Baker · 2010 [cited by applicant]
US 20110066216A1 · Ting et al. · 2011 [cited by applicant]
US 20110155143A1 · Shantha · 2011 [cited by applicant]
US 20110166598A1 · Gonazles et al. · 2011 [cited by applicant]
US 20110224761A1 · Manstein · 2011 [cited by applicant]
US 20110238050A1 · Allison et al. · 2011 [cited by applicant]
US 20110238051A1 · Levinson et al. · 2011 [cited by applicant]
US 20110300079A1 · Martens et al. · 2011 [cited by applicant]
US 20120022518A1 · Levinson et al. · 2012 [cited by applicant]
US 20120085174A1 · Urbano · 2012 [cited by applicant]
US 20120239123A1 · Weber et al. · 2012 [cited by applicant]
US 20120265186A1 · Burger · 2012 [cited by applicant]
US 20130066309A1 · Levinson et al. · 2013 [cited by applicant]
US 20130079684A1 · Rosen et al. · 2013 [cited by applicant]
US 20130116758A1 · Levinson et al. · 2013 [cited by applicant]
US 20130116759A1 · Levinson et al. · 2013 [cited by applicant]
US 20130158440A1 · Allison · 2013 [cited by applicant]
US 20130158636A1 · Ting et al. · 2013 [cited by applicant]
US 20130245731A1 · Allison · 2013 [cited by applicant]
US 20130253384A1 · Anderson et al. · 2013 [cited by applicant]
US 20130253494A1 · Anderson et al. · 2013 [cited by applicant]
US 20130253495A1 · Anderson et al. · 2013 [cited by applicant]
US 20130253496A1 · Anderson et al. · 2013 [cited by applicant]
US 20140005760A1 · Levinson et al. · 2014 [cited by applicant]
US 20140067025A1 · Levinson et al. · 2014 [cited by applicant]
US 20140257443A1 · Baker et al. · 2014 [cited by applicant]
US 20140277219A1 · Nanda · 2014 [cited by applicant]
US 20140277302A1 · Weber · 2014 [cited by examiner]
US 20140316393A1 · Levinson et al. · 2014 [cited by applicant]
US 20150047301A1 · Messersi' · 2015 [cited by applicant]
US 20150148791A1 · Birdsall et al. · 2015 [cited by applicant]
US 20150216719A1 · DeBenedictis et al. · 2015 [cited by applicant]
US 20150216720A1 · DeBenedictis et al. · 2015 [cited by applicant]
US 20150216816A1 · O'Neil et al. · 2015 [cited by applicant]
US 20150251120A1 · Jakop · 2015 [cited by applicant]
US 20160022345A1 · Baust et al. · 2016 [cited by applicant]
US 20160051401A1 · Yee et al. · 2016 [cited by applicant]
US 20160183997A1 · Burnett et al. · 2016 [cited by applicant]
US 20160324576A1 · Ebbutt · 2016 [cited by applicant]
US 20160338752A1 · Sperling · 2016 [cited by applicant]
US 20160354234A1 · Dabrowiak · 2016 [cited by applicant]
US 20160354237A1 · Gonzales · 2016 [cited by examiner]
US 20170079833A1 · Frangineas et al. · 2017 [cited by applicant]
US 20170105869A1 · Frangineas · 2017 [cited by applicant]
US 20170196731A1 · DeBenedictis et al. · 2017 [cited by applicant]
US 20170239079A1 · Root et al. · 2017 [cited by applicant]
US 20170246032A1 · Gonzales et al. · 2017 [cited by applicant]
US 20170325992A1 · DeBenedictis et al. · 2017 [cited by applicant]
US 20170325993A1 · Jimenez Lozano et al. · 2017 [cited by applicant]
US 20170326042A1 · Zeng et al. · 2017 [cited by applicant]
US 20170326346A1 · Jimenez Lozano et al. · 2017 [cited by applicant]
US 20180185081A1 · O'Neil et al. · 2018 [cited by applicant]
US 20180206900A1 · Sperling · 2018 [cited by applicant]
US 20180235805A1 · Burger et al. · 2018 [cited by applicant]
US 20190069949A1 · Vrba · 2019 [cited by examiner]
US 20190151006A1 · Fourkas et al. · 2019 [cited by applicant]
US 20190192873A1 · Schwarz et al. · 2019 [cited by applicant]
US 20190197361A1 · Gonzales et al. · 2019 [cited by applicant]
US 20190254867A1 · Gonzales et al. · 2019 [cited by applicant]
US 20190290347A1 · Elkins et al. · 2019 [cited by applicant]
US 20200046552A1 · Velis et al. · 2020 [cited by applicant]
US 20200069458A1 · Pham · 2020 [cited by applicant]
US 20200138501A1 · DeBenedictis et al. · 2020 [cited by applicant]
US 20200206024A1 · Karnik et al. · 2020 [cited by applicant]
US 20200222103A1 · Manstein · 2020 [cited by applicant]
US 20200268439A1 · Frazier et al. · 2020 [cited by applicant]
US 20200323682A1 · O'Connor et al. · 2020 [cited by applicant]
US 20200375647A1 · Alphandery et al. · 2020 [cited by applicant]
US 20210030457A1 · Avram et al. · 2021 [cited by applicant]
US 20210038278A1 · DeBenedictis et al. · 2021 [cited by applicant]
US 20210128219A1 · Allison et al. · 2021 [cited by applicant]
US 20210186585A1 · Burger et al. · 2021 [cited by applicant]
US 20210282829A1 · O'Neil et al. · 2021 [cited by applicant]
US 20210315626A1 · Xiao et al. · 2021 [cited by applicant]
US 20210322084A1 · Velis et al. · 2021 [cited by applicant]
US 20210353351A1 · Mazor et al. · 2021 [cited by applicant]
US 20220008110A1 · Velis et al. · 2022 [cited by applicant]
US 20220047315A1 · Baker et al. · 2022 [cited by applicant]
US 20220071802A1 · Christopherson et al. · 2022 [cited by applicant]
US 20220125630A1 · Karnik et al. · 2022 [cited by applicant]
US 20220133531A1 · Salma et al. · 2022 [cited by applicant]
US 20220226206A1 · Velis et al. · 2022 [cited by applicant]
US 20220233863A1 · Rondoni et al. · 2022 [cited by applicant]
US 20220257272A1 · Wolf et al. · 2022 [cited by applicant]
US 20220265344A1 · Wolf, II et al. · 2022 [cited by applicant]
US 20220280788A1 · Verzal et al. · 2022 [cited by applicant]
US 20220288388A1 · Rondoni · 2022 [cited by applicant]
US 20220296887A1 · Johnson et al. · 2022 [cited by applicant]
US 20220338892A1 · Iyer et al. · 2022 [cited by applicant]
US 20220346852A1 · Anderson et al. · 2022 [cited by applicant]
US 20220387091A1 · DeBenedictis et al. · 2022 [cited by applicant]
US 20220401725A1 · Dieken et al. · 2022 [cited by applicant]
US 20220401727A1 · Rondoni et al. · 2022 [cited by applicant]
US 20230000669A1 · Babkin et al. · 2023 [cited by applicant]
US 20230028322A1 · Velis et al. · 2023 [cited by applicant]
US 20230031549A1 · Velis et al. · 2023 [cited by applicant]
US 20230046154A1 · Mazor et al. · 2023 [cited by applicant]
US 20230046673A1 · Velis et al. · 2023 [cited by applicant]
US 20230054472A1 · Hill et al. · 2023 [cited by applicant]
US 20230240887A1 · Gonzales et al. · 2023 [cited by applicant]
US 20240341830A1 · Kannan et al. · 2024 [cited by applicant]
US 20240341831A1 · Kannan et al. · 2024 [cited by applicant]
US 20250134915A1 · Gonzales et al. · 2025 [cited by applicant]
US 20250135004A1 · Gonzales et al. · 2025 [cited by applicant]
AU 2011279923B2 · 2016 [cited by applicant]
AU 2018226785A1 · 2019 [cited by applicant]
AU 2020272238A1 · 2021 [cited by applicant]
AU 2020412601A1 · 2022 [cited by applicant]
AU 2021324991A1 · 2023 [cited by applicant]
CA 3023821A1 · 2017 [cited by applicant]
CA 3044020A1 · 2018 [cited by applicant]
CA 3065606A1 · 2018 [cited by applicant]
CA 3115260A1 · 2020 [cited by applicant]
CA 3135707A1 · 2020 [cited by applicant]
CA 3162660A1 · 2021 [cited by applicant]
CN 108836619A · 2018 [cited by applicant]
EP 1890627B1 · 2012 [cited by applicant]
EP 2111172B1 · 2013 [cited by applicant]
EP 2094328B1 · 2014 [cited by applicant]
EP 2676623B1 · 2015 [cited by applicant]
EP 2162083B1 · 2015 [cited by applicant]
EP 2499984B1 · 2016 [cited by applicant]
EP 2967706A1 · 2016 [cited by applicant]
EP 2687174B1 · 2016 [cited by applicant]
EP 3099258A1 · 2016 [cited by applicant]
EP 3099260A2 · 2016 [cited by applicant]
EP 3182918A1 · 2017 [cited by applicant]
EP 2802279B1 · 2017 [cited by applicant]
EP 3104796B · 2019 [cited by applicant]
EP 3488833A1 · 2019 [cited by applicant]
EP 3541345A1 · 2019 [cited by applicant]
EP 3342379B1 · 2019 [cited by applicant]
EP 3506846A4 · 2021 [cited by applicant]
EP 3099262B1 · 2022 [cited by applicant]
EP 4081746A1 · 2022 [cited by applicant]
GB 2423023B · 2009 [cited by applicant]
HK 40011648A · 2020 [cited by applicant]
IL 266662A · 2019 [cited by applicant]
IL 269038A · 2019 [cited by applicant]
JP H01223961A · 1989 [cited by applicant]
JP 2022126649A · 2022 [cited by applicant]
MX 2019010396A · 2020 [cited by applicant]
SG 11201908076 · 2019 [cited by applicant]
SG 11202103368 · 2021 [cited by applicant]
SG 11202103636 · 2021 [cited by applicant]
WO WO9744092A1 · 1997 [cited by applicant]
WO WO99003411A1 · 1999 [cited by applicant]
WO WO2003078596A2 · 2003 [cited by applicant]
WO 2007101039A1 · 2007 [cited by applicant]
WO 2007127924A2 · 2007 [cited by applicant]
WO 2007133839A1 · 2007 [cited by applicant]
WO 2008016730A2 · 2008 [cited by applicant]
WO 2008039556A1 · 2008 [cited by applicant]
WO 2008039557A1 · 2008 [cited by applicant]
WO 2008060423A2 · 2008 [cited by applicant]
WO WO2008055243A2 · 2008 [cited by applicant]
WO 2008143678A1 · 2008 [cited by applicant]
WO 2009011708A1 · 2009 [cited by applicant]
WO WO2009026471A1 · 2009 [cited by applicant]
WO WO2010036732A1 · 2010 [cited by applicant]
WO WO2010127315A2 · 2010 [cited by applicant]
WO WO2011091293A1 · 2011 [cited by applicant]
WO WO2011091431A1 · 2011 [cited by applicant]
WO 2012012296A1 · 2012 [cited by applicant]
WO WO2012103242A1 · 2012 [cited by applicant]
WO WO2012103315A2 · 2012 [cited by applicant]
WO 2014151850A2 · 2014 [cited by applicant]
WO 2014151872A2 · 2014 [cited by applicant]
WO WO2016033384A1 · 2016 [cited by applicant]
WO WO2017223417A1 · 2017 [cited by applicant]
WO WO2018044825A1 · 2018 [cited by applicant]
WO 2019046236A2 · 2019 [cited by applicant]
WO 2020142519A1 · 2020 [cited by applicant]
WO WO2022169699A1 · 2022 [cited by applicant]
WO 2022229277A1 · 2022 [cited by applicant]
WO 2023278891A1 · 2023 [cited by applicant]
WO 2023064528A1 · 2023 [cited by applicant]
Avram et al., Cryolipolysis for Subcutaneous Fat Layer Reduction, Lasers in Surgery and Medicine, 41: 703-708; Dec. 2009. [cited by applicant]
Coleman et al., Clinical Efficacy of Noninvasive Cryolipolysis and Its Effects on Peripheral Nerves, Aesth. Plast. Surg., 33: 482-488; Mar. 2009. [cited by applicant]
Day et al.; Popsicle Panniculitis; Pediatric Emergency Care; 8(2); 91-93; Apr. 1992. [cited by applicant]
Epstein et al.; Popsicle Panniculitis; NEJM; 282(17); 966-967; Apr. 23, 1970. [cited by applicant]
Gage et al.; Critical temperature for skin necrosis in experimental cryosurgery; Cryobiology; 19(3); pp. 273-282; Jun. 1982. [cited by applicant]
Kim et al.; Tongue fat and its relationship to obstructive sleep apnea; Sleep; 37(10); pp. 1639-1648; Oct. 2014. [cited by applicant]
Medicalxpress; Study shows that tongue size and fat may predict sleep apnea risk in obese adults; 3 pages retrived from the interenet (https://medicalxpress.com/news/2014-09-tongue-size-fat-apnea-obese.html) on Nov. 27,… [cited by applicant]
Nelson et al., Cryolipolysis for Reduction of Excess Adipose Tissue; Semin. Cutan. Med. Surg., 28(4): 244-249; Dec. 1, 2009. [cited by applicant]
Rajkumar et al.; Popsicle Panniculitis of the Cheeks; Clinical Pediatrics.; 15(7); 619-621; Jul. 1976. [cited by applicant]
Zelickson et al., Cryolipolysis for Noninvasive Fat Cell Destruction: Initial Results from a Pig Model; Dermatol. Surg., 35: 1462-1470; Oct. 2009. [cited by applicant]
Gonzalez et al., U.S. Appl. No. 18/058,159 entitled “Apparatus and Methods for Treatment of Obstructive Sleep Apnea Utilizing Cryolysis of Adipose Tissues,” filed Nov. 22, 2022. [cited by applicant]
Extended European Search Report mailed Apr. 9, 2018 in European Patent Application No. 15846755.5, 9 pages. [cited by applicant]
Extended European Search Report mailed Aug. 19, 2022 in European Patent Application No. 19907538.3, 8 pages. [cited by applicant]
Extended European Search Report mailed Dec. 15, 2023 in European Patent Application No. 21756850.0, 8 pages. [cited by applicant]
International Search Report mailed Dec. 28, 2015 in International Patent Application No. PCT/US15/51903, 10 pages. [cited by applicant]
International Search Report mailed Jun. 29, 2021 in International Patent Application No. PCT/US21/18926, 12 pages. [cited by applicant]
International Search Report mailed Jun. 6, 2023 in International Patent Application No. PCT/US22/82620, 11 pages. [cited by applicant]
International Search Report mailed May 1, 2020 in International Patent Application No. PCT/US19/69113, 11 pages. [cited by applicant]
International Search Report mailed May 16, 2012 in International Patent Application No. PCT/US12/22697. [cited by applicant]
Office Action mailed Jul. 18, 2017 in Canadian Patent Application No. 2,825,624, 3 pages. [cited by applicant]
Office Action mailed Jul. 18, 2018 in Canadian Patent Application No. 2,825,624, 4 pages. [cited by applicant]
Office Action mailed Jul. 25, 2023 in Japanese Patent Application No. 2021-538451, 7 pages, English Translation. [cited by applicant]
Office Action mailed Oct. 27, 2021 in Canadian Patent Application No. 2,962,920, 5 pages. [cited by applicant]
Office Action mailed Sep. 13, 2023 in Canadian Patent Application No. 3, 168,812, 4 pages. [cited by applicant]
Office Action mailed Sep. 22, 2023 in Canadian Patent Application No. 3, 125,291, 5 pages. [cited by applicant]
Chakrabarti, P. et al., “FoxO1 controls insulin-dependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes,” Journal of biological chemistry, 2009, vol. 284, No. 20, pp. 13296-13300. [cited by applicant]
Decision of Dismissal of Amendment mailed Nov. 12, 2024 in Japanese Patent Application No. 2021-538451, 4 pages, with English Translation. [cited by applicant]
Examination Report mailed Aug. 15, 2024 in Canadian Patent Application No. 3,125,291, 5 pages. [cited by applicant]
Examination Report mailed Aug. 15, 2024 in Canadian Patent Application No. 3, 168,812, 4 pages. [cited by applicant]
Examination Report mailed Jul. 10, 2024 in European Patent Application No. 19907538.3, 4 pages. [cited by applicant]
Examination Report mailed Sep. 16, 2024 in Australian Patent Application No. 2019419502, 4 pages. [cited by applicant]
Ichioka, M. et al., “Increased expression of macrophage-inducible C-type lectin in adipose tissue of obese mice and humans,” Diabetes, 2011, vol. 60, pp. 819-826. [cited by applicant]
International Search Report and Written Opinion mailed Jan. 31, 2025 in International Patent Application No. PCT/US24/51836, 10 pages. [cited by applicant]
Keuper, M. et al., “An inflammatory micro-environment promotes human adipocyte apoptosis,” Molecular and cellular endocrinology, 2011, vol. 339, pp. 105-113. [cited by applicant]
Office Action mailed Apr. 16, 2024 in Japanese Patent Application No. 2021-538451, 4 pages, English Translation. [cited by applicant]
Tanaka, M. et al., “Macrophage-inducible C-type lectin underlies obesity-induced adipose tissue fibrosis,” Nature communications, 2014, vol. 5, article:4982, pp. 1-13. [cited by applicant]